|
Facebook
Twitter
Linkedin
|
Central Manchester University Hospitals with Siemens mCT
| Company News - Siemens Healthcare |
Siemens Healthcare 's innovative hybrid imaging system to benefit cancer patients and paediatric services
Central Manchester University Hospitals NHS Foundation Trust is one of a few sites in the UK to use the Biograph mCT from Siemens Healthcare in routine clinical service. The new concept scanner combines cutting-edge CT technology with HD•PET to provide a new depth of information. It offers specific, detailed information about a patient’s disease state, including cell metabolism within tumours.
The Biograph mCT is the world’s only PET system that offers a uniform 2mm image resolution throughout the entire field of view. This significantly improves image quality and offers clinicians increased diagnostic confidence. It can also achieve five minute, whole-body PET scans and has a large bore and short tunnel for a more comfortable scanning experience for the patient. Due to its dual functionality, the system can also be used as a combined molecular CT or as a standalone, high power CT scanner if required, saving the time, cost and space restrictions associated with multiple imaging installations.
The system obtains a great depth of diagnostic information during one, noninvasive examination, adapting to virtually any patient and any clinical need with higher resolution, contrast and speed. The ability to visualise the metabolic functions of the body and the patient’s anatomy at the same time also means diseased tissue can be more accurately located, ensuring the patient is given the most appropriate course of treatment.
Located within the Central Manchester Nuclear Medicine Centre, the hybrid Biograph mCT has been installed in a dedicated imaging suite and significantly enhances the Nuclear Medicine service for patients from the Trust and beyond. It is being used in the management of cancer patients and from May will also be used to fulfil a cardiology service with rubidium to assess blood perfusion in the heart. There are also plans to develop specialist brain and paediatric imaging services.
“We needed a PET•CT system that could perform efficiently and produce excellent results for a range of examinations including cardiology, neurology and oncology in adult and paediatric patients. The Biograph mCT ticks all these boxes and we now have a future-proof solution to meet evolving Trust and patient needs,” said Dr. Heather Williams, Senior Medical Physicist for Nuclear Medicine at Central Manchester University Hospitals NHS Foundation Trust. “The performance of the mCT to date has surpassed our expectations and we’re looking forward to demonstrating its capabilities for clinical applications and research.”
“The Biograph mCT is the ultimate in imaging efficiency and is a next generation solution to today’s challenging health economy,” said Lawrence Foulsham, Product Manager for Molecular Imaging and Oncology at Siemens Healthcare. “With advanced CT capabilities and high-definition PET, its potential for making costs savings plus improving departmental efficiency is enormous.”
Source: Siemens Healthcare











